In 1994 we repeated a study first performed in 1989 to assess the change in general practitioners' use of and attitudes to peak flow measurement. Of 232 general practitioners surveyed, 199 (86 %) and 192 (83%) responded in 1989 and 1994 respectively. The percentage who reported having patients using domiciliary peak flow monitoring rose from 58.3 (95% confidence limits 51.4 to 65.2) % to 97.9 (95.9 to 99.9) %. The percentage who reported 'usually' using peak flow measurements for the diagnosis and management of asthma rose from 81.9 (76.5 to 87.3) % to 93.2 (89.6 to 96.8)% and from 83.3 (78.1 to 88.5)% to 95.8 (92.9 to 98.7)% respectively. An unchanged proportion took peak flow meters on house calls. General practitioners have become more aware of the potential of peak flow measurements but are still unlikely to have a meter available to assess patients seen at home. They are therefore likely to be ill-equipped to manage acute exacerbations of asthma in this setting.
INTRODUCTION
Peak flow meters became available by National Health Service prescription in 1990. This was accompanied by considerable discussion of peak flow monitoring in the medical press. The British Thoracic Society included a firm recommendation for their use in its guidelines on the management of asthma as well as emphasising the importance of peak flow measurements for the assessment of acute asthma exacerbations.'
In 1989, a survey of a one in four sample of general practitioners in Northern Ireland showed that almost all had access to a peak flow meter and many were using them for the diagnosis and management of asthma.2 Almost 60% of the sample had at least one patient using domiciliary peak flow monitoring although few practitioners took peak flow meters on house calls. 2 This survey has been repeated to determine whether these general practitioners' attitudes to General practitioners continue to report that they use peak flow meters more for the management and diagnosis of asthma than for chronic obstructive airways disease, and use them equally for the diagnosis and management of asthma (Table I) . Although their reported use of the meters for diagnosis and management of chronic obstructive airways disease has not changed, it has increased for asthma (Table I) . From the paired comparison, the likelihood of a respondent changing practice to 'usually' using peak flow meters for the diagnosis of asthma was 3.7 (95% confidence limits 1.2 to 15.5) and 5.7 1.6 to 30.2) for asthma management. In 1989, 58.3 (95% confidence limits 51.4 to 65.2)% of practitioners reported that they had at least one patient who was using domiciliary peak flow monitoring and by 1994 this had risen to 97.9 (95.9 to 99.9)%, an increase of 39.6 (32.5-46.7)%. Respondents' estimates of the number of asthmatic patients using peak flow monitoring rose from a median (inter-quartile range) of 5 (2 to 10) to 30 (5 to 50) with a seven-fold increase in their estimate of the total number using peak flow meters at home. Table II shows practitioners' attitudes to the usefulness of peak flow meters when used in the consulting room, and by patients for domiciliary monitoring. Most now feel that peak flow measurements in the consulting room are either 'very useful' or 'useful' for the diagnosis and management of asthma. The paired comparison showed that the likelihood of a respondent changing his/her opinion in 1989 that peak flow meters were of 'some use' or 'no use' for the diagnosis of asthma in the consulting room to their being 'very useful' or 'useful' in 1994 was 3 (95% confidence limits 1.04 to 10.6). The probability of a similar change in their opinion of the usefulness of peak flow meters for the 
